Global Vaccine Adjuvants Market Research Report, Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023 - ResearchAndMarkets.com

DUBLIN--()--The "Global Vaccine Adjuvants Market Research Report, Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report has been added to ResearchAndMarkets.com's offering.

Adjuvants are the immunological agents deployed in vaccines for enhancing body's immune response to the vaccine and its ability to induce protection against infection. The global vaccine adjuvants market is growing at a CAGR of 10.25% during forecast period 2016-2023.

Increasing use of adjuvants in vaccine, high prevalence of infectious diseases and zoonotic diseases, increasing government focus on immunization programs, increasing geriatric population and increasing R&D in vaccine adjuvants are driving the growth of the market. According to Centre for Disease Control and Prevention, zoonotic diseases prevalence is found to be common in U.S. and around 10,000 American population every year get infected from germs that are communicable through animals. Further, it is stated that every 6 out of 10 people are infected from known infectious disease spread by animals. Moreover, occurrence of these diseases are found in children above age 5 and in adults of 65 age and above along with people having weak immune system.

Increasing focus on immunization programs by governments has accelerated growth of market. For instance, U.S. National Adult Immunization Program targeting specifically adults for vaccination with a goal of strengthening immunization infrastructure for adults, to develop better access to vaccines for adults, and develop new technologies related to vaccination and adult vaccine innovation. Further, India's Universal Immunization Program (U.I.P) is one of the world's largest programs in terms of quantities of vaccines used in program, in terms of area covered by program, in number of benefited peoples and programs organized. Further, China National Immunization Program is a government program with a goal to eliminate and control vaccine preventable diseases.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Geographical Analysis

7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/3hqp73/global_vaccine?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Vaccines

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Vaccines